Elsevier

Behavioural Brain Research

Volume 184, Issue 1, 22 November 2007, Pages 81-90
Behavioural Brain Research

Research report
Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: Short- and long-term memory

https://doi.org/10.1016/j.bbr.2007.06.026Get rights and content

Abstract

In order to determine whether short- (STM) and long-term memory (LTM) function in serial or parallel manner, serotonin (5-hydroxtryptamine, 5-HT) receptor agonists were tested in autoshaping task. Results show that control-vehicle animals were modestly but significantly mastering the autoshaping task as illustrated by memory scores between STM and LTM. Thus, post-training administration of 8-OHDPAT (agonist for 5-HT1A/7 receptors) only at 0.250 and 0.500 mg/kg impaired both STM and LTM. CGS12066 (agonist for 5-HT1B) produced biphasic affects, at 5.0 mg/kg impaired STM but at 1.0 and 10.0 mg/kg, respectively, improved or impaired LTM. DOI (agonist for 5-HT2A/2C receptors) dose-dependently impaired STM and, at 10.0 mg/kg only impaired LTM. Both, STM and LTM were impaired by either mCPP (mainly agonist for 5-HT2C receptors) or mesulergine (mainly antagonist for 5-HT2C receptors) lower dose. The 5-HT3 agonist mCPBG at 1.0 impaired STM and its higher dose impaired both STM and LTM. RS67333 (partial agonist for 5-HT4 receptors), at 5.0 and 10.0 mg/kg facilitated both STM and LTM. The higher dose of fluoxetine (a 5-HT uptake inhibitor) improved both STM and LTM. Using as head-pokes during CS as an indirect measure of food-intake showed that of 30 memory changes, 21 of these were unrelated to the former. While some STM or LTM impairments can be attributed to decrements in food-intake, but not memory changes (either increase or decreases) produced by 8-OHDPAT, CGS12066, RS67333 or fluoxetine. Except for animals treated with DOI, mCPBG or fluoxetine, other groups treated with 5-HT agonists 6 h following autoshaping training showed similar LTM and unmodified CS–head-pokes scores.

Introduction

Growing evidence from invertebrate [2], [3], [4], [27] and mammalian species, including human shows [66], [67] that serotonin (5-hydroxytryptamine, 5-HT) systems play a role in memory consolidation, short- (STM) and long-term memory (LTM) [7], [21], [39], [44]. In mammalian species, these cognitive processes occur in brain areas such as hippocampus, amygdala, caudate nucleus, hypothalamus and cortex. Significant changes in brain 5-HT systems function and receptors appear as results of memory formation, aging and Alzheimer's disease (see [44], [49], for review; also [11], [17], [29], [32], [36], [39], [47], [49], [50], [57], [69]). Notably, using receptor binding profiles, common secondary messenger coupling and functional activity ligands, seven families of 5-hydroxytryptamine receptors and subtypes (5-HT1A/1B/1D/1E/1F, 5-HT2A/2B/2C, 5-HT3A/3B, 5-HT4A/4B, 5-HT5A/5B, 5-HT6 and 5-HT7A/7B/7C/7D) have been identified [18], [19], [61], [62]. Timely questions are the nature of memory [14], including the pharmacological, molecular and theoretical basis of STM and LTM. It is unknown if STM is merely a step towards LTM, or both are separate entities [23], [25]. Direct participation of 5-HT has been demonstrated in human and animals by decreasing 5-HT brain levels using acute 5-HT depletion, which impaired memory formation (see [12], [65], [67] for reviews); in contrast, enhancing brain serotonin activity by means of its precursor (i.e., tryptophan) improved memory in animals ([15], see [51], for review). This evidence is consistent with the result that post-training (but not pre-) administration of 5-HT uptake inhibitors improved memory consolidation by increasing 5-HT intersynaptic concentrations, requiring protein and mRNA synthesis of multiple 5-HT receptors ([40], [41], [42]; see also e.g., [50]). This notion is consistent with the fact that 5-HT itself displays a differential affinity for 5-HT receptors [40]. 5-HT systems might exert their effects directly and/or by modulating neurotransmitters such as acetylcholine and glutamate (see for e.g., [7], [20], [33], [39]), then it is possible that by augmenting 5-HT tone of different 5-HT receptors during memory formation, this cognitive process would be affect. As STM temporarily stores information on the basis of changes in preexisting connections due to covalent modifications of preexisting proteins and LTM stores this information more permanently through the growth of new connections as a result of transcription and translation of certain genes, a process called memory consolidation [1], [6], [13], [22], [24], [25], [26], [27], [38], [39], [70]. Notably, 5-HT receptors are metabotropic or ionotropic [19] they depict different times and duration courses of action as well differential affinity for serotonin (see [40]), which would provide might support to STM and/or LTM. Hence, the aim in this work was to determine the effects of agonists for 5-HT1A to 5-HT4 receptors or 5-HT uptake inhibitor in STM and LTM by using an associative learning task, namely autoshaping, where memory formation is gradually and progressive [39]. Herein, STM and LTM are define in terms of their neurobiological basis, since it was previously reported [39] that the inhibition of hippocampal protein synthesis or new mRNA did not produce a significant effect on autoshaping STM performance but it did impair LTM; nonetheless their non-contingent administration of protein inhibitors at 6 or 24 h following training [39] or immediately before testing showed no effects.

It should be noticed that from invertebrates to mammalians the same animals have been used to study STM and LTM [23], [27], [39], in behavioral tasks requiring one trial (e.g., passive avoidance) as well as multitrial and progressive process (e.g., gill withdrawal reflex in Aplysia). Hence, in this study Pavlovian/instrumental autoshaping (P/I-A) learning task was selected because requires multitrial, which generates a gradual learning of conditioned responses (CR) [39], [40], [44], [46]. Notably, a large number of serotonergic and physiological (e.g., aging) mechanisms have been tested in autoshaping and the present doses were selected in base to previous dose-response studies (see [39], [40], [56]), which produced reproducible effects in memory consolidation or STM and LTM. In an autoshaping or sign-tracking setting, a hungry animal is given a Pavlovian sequential pairing (stimulus–stimulus [S–S]) of a lighted key or a retractable-illuminated lever conditioned stimulus (CS) and unconditioned stimulus (US) (for review see [40]). Autoshaped responses or conditioned responses (CR) result from the Pavlovian S–S association and are sustained by the instrumental response–stimulus (R–S) association such as peck, lever-press or contact lever-press responses. Autoshaping is sensitive to small increases or decreases in various behavioral parameters (i.e., not measuring the same event twice), including sign tracking (i.e., autoshaping response directed toward to the localized retractable and illuminated lever) and goal tracking (i.e., heads-pokes directed to the food-magazine, the place where the US is delivered). Importantly, Pavlovian S–S and R–S associations are mediated by hippocampus and striatum, respectively [40] and these associations have allowed using important behavioral control. For instance, comparison between a trained group with P/I-A associations showed 10–15% of CR, during the second and third sessions; in contrast, truly random control group [63] displayed 3–5% of CR [51], while the operant level was 0.6% of CR [40]. Importantly, increases or decreases of the autoshaped response may be independent of food intake, since animals do not learn the CR under diverse conditions of food-deprivation levels [46] and pre- or post-training administration of drugs that increase (e.g., 8-hydroxy-2-(di-n-propylamino) tetralin, 8-OH-DPAT) food-intake in free-feeding animals, had no effect in retrained animals with food deprivation; however, 8-OH-DPAT increased the CR in free-feeding groups in a dose-dependent manner. Notably, a well-known suppresser of food-intake such as d-amphetamine facilitated memory consolidation in a P/I-A task in food-deprived rats [54] and in a recent work ([39], see also [30]) 5-HT, cholinergic or glutamatergic antagonists modulated STM and LTM regardless to head-pokes during CS (CS–head-pokes). It should be keep in mind that some 5-HT drugs could produce some unspecific motor or e.g., food-intake effects, hence it is important to have some behavioral (indirect) index of food-intake during the STM and LTM experiments. In this work, head-pokes/CS was used as an indirect index to detect food-intake. To our knowledge there is no previous evidence about the effects of 5-HT receptor agonists in STM and LTM.

Section snippets

Subjects

Male Wistar rats (12-weeks-old, weight, 230–260 g) were collectively housed (n = 8–10) in jumbo cage (53 cm × 43 cm × 19 cm), in a temperature- and light-controlled room under a 12 h light/dark cycle (lights on at 7:00 a.m.) at a constant temperature of 23 °C, with water and food provided ad libitum for a week. This was eventually followed by a reduction in body weights to 85% by gradually reducing the food-intake (see below). The local institutional committee for the use of animal subjects approved the

Effects of 5-HT1 receptors

The control-vehicle groups scored 3 ± 2% of CR during the training session, while during STM 7 ± 2% of CR and LTM, 15 ± 5% of CR, thus showing that these control-vehicle animals were modestly but significantly mastering the autoshaping task as confirmed by the differences in head-pokes/CS number of control groups between STM and LTM (Table 1). Post-training administration of the 5-HT1A receptor agonist 8-OHDPAT at 0.31–1.0 mg/kg had no effect and only at 0.250 and 0.500 mg/kg significantly [F(5,47) = 

Discussion

The major results of the present work show that post-training administration of 8-OHDPAT only at 0.250 and 0.500 mg/kg significantly impaired both STM and LTM relative to the control group. Administration of CGS12066 produced biphasic effects, at 5.0 mg/kg impaired STM but at 1.0 and 10.0 mg/kg improved or impaired, respectively, STM and LTM. DOI dose-dependently impaired STM and, at 1.0 mg/kg impaired only LTM. Both STM and LTM were impaired by either mCPP or mesulergine lower dose. At 1.0 mg/kg

Conclusions

The present data clearly demonstrated that it is possible to separately study STM and LTM. Of 30 memory changes, in 21 either memory or head-pokes/CS scores there were discrepant. While some STM or LTM impairments can be attributed to decreases in food-intake, those changes (i.e., increase or decreases) induced by 8-OHDPAT, CGS12066, RS 67333 or fluoxetine did not. Except for CGS12066, in these cases STM and LTM functioned in serial manner. The present conclusions should be taken with caution

References (70)

  • L. Manuel-Apolinar et al.

    8-OH-DPAT facilitated memory consolidation and increased hippocampal and cortical cAMP production

    Behav Brain Res

    (2004)
  • J.L. McGaugh et al.

    The contribution of pharmacology to research on the mechanisms of memory formation

    Trends Pharmacol Sci

    (2000)
  • A. Meneses

    Do serotonin1–7 receptors modulate short and long-term memory?

    Neurobiol Learn Mem

    (2007)
  • A. Meneses

    Tianeptine: 5-HT uptake sites and 5-HT1–7 receptors modulate memory formation in an autoshaping Pavlovian/instrumental task

    Neurosci Biobehav Rev

    (2002)
  • A. Meneses

    Could the 5-HT1B receptor inverse agonism affect learning consolidation?

    Neurosci Biobehav Rev

    (2001)
  • A. Meneses

    5-HT system and cognition

    Neurosci Biobehav Rev

    (1999)
  • A. Meneses et al.

    Modification of 8-OH-DPAT effects on learning by manipulation of the assay conditions

    Behav Neural Biol

    (1994)
  • A. Meneses et al.

    Expression of the 5-HT receptors in rat brain during memory consolidation

    Behav Brain Res

    (2004)
  • A. Meneses et al.

    Memory consolidation and amnesia modify 5-HT6 receptors expression in rat brain: autoradiographic study

    Behav Brain Res

    (2007)
  • A. Meneses et al.

    5-HT1A and memory

    Neurosci Biobehav Rev

    (2007)
  • G.S. Perez-Garcia et al.

    Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task

    Behav Brain Res

    (2005)
  • G. Perez-Garcia et al.

    Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task

    Pharmacol Biochem Behav

    (2005)
  • G. Perez-Garcia et al.

    An mRNA expression analysis of stimulation and blockade of 5-HT7 receptors during memory consolidation

    Behav Brain Res

    (2006)
  • G. Piñeyro et al.

    5-HT1D receptors regulate 5-HT release in the rat raphe nuclei

    Neuropharmacology

    (1995)
  • B.J. Piper

    A developmental comparison of the neurobehavioral effects of ecstasy (MDMA)

    Neurotoxicol Teratol

    (2007)
  • J.R. Raymond et al.

    Multiplicity of mechanisms of serotonin receptor signal transduction

    Pharmacol Ther

    (2001)
  • A. Sambeth et al.

    Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studies

    Neurosci Biobehav Rev

    (2007)
  • H.P. Schmitt

    Neuro-modulation, aminergic neuro-disinhibition and neuro-degeneration. Draft of a comprehensive theory for Alzheimer disease

    Med Hypotheses

    (2005)
  • H. Wang et al.

    Molecular and systems mechanisms of memory consolidation and storage

    Prog Neurobiol

    (2006)
  • D. Barbas et al.

    Multiple serotonergic mechanisms contributing to sensitization in Aplysia: evidence of diverse serotonin receptor subtypes

    Learn Mem

    (2003)
  • D. Barbas et al.

    Comparative localization of two serotonin receptors and sensor in the central nervous system of Aplysia californica

    J Comp Neurol

    (2005)
  • D.M. Barros et al.

    Pharmacological findings contribute to the understanding of the main physiological mechanisms of memory retrieval

    Curr Drug Targets CNS Neurol Disord

    (2003)
  • M.C. Buhot et al.
  • K.A. Berg et al.

    Agonist-directed trafficking of 5-HT receptor-mediated signal transduction

  • P. Celada et al.

    Modulation of the neuronal activity and neurotransmitter release by 5-HT1A and 5-HT1B/1D receptors

  • Cited by (0)

    View full text